安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- AstraZeneca | Cafepharma Message Boards | Pharma Sales, Device Sales . . .
Anonymous board for AstraZeneca We’ve brought the Cafepharma Job Board back If you’re hiring—or looking— check out the latest listings
- AstraZeneca | Cafepharma
AstraZeneca is pouring $136 million more into the expansion of an inhalants production base in China The latest investment brings the British pharma’s total investment at the site in Qingdao to $886 million AstraZeneca unveiled (Chinese) the outlay Wednesday at the China International Import Expo (CIIE), an annual event where foreign companies parade their commitments to the country
- Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Anonymous discussion boards for pharmaceutical sales, medical device sales, lab diagnostics sales
- November 6 2025 - With 2030 ambitions in view, AstraZeneca’s quarterly . . .
With 2030 ambitions in view, AstraZeneca’s quarterly revenue passes $15B for first timeAstraZeneca boardEli Lilly links amylin agonist to 20% weight loss, sparking charge into phase 3Eli Lilly boardNovartis’ Pluvicto heavywork proves radiopharma can succeedNovartis boardJ J adds first new indication for Caplyta since takeover
- Pfizer | Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Anonymous board for Pfizer We’ve brought the Cafepharma Job Board back If you’re hiring—or looking— check out the latest listings
- GlaxoSmithKline | Cafepharma Message Boards | Pharma Sales, Device . . .
Anonymous board for GlaxoSmithKlineWe’ve brought the Cafepharma Job Board back If you’re hiring—or looking— check out the latest listings
- AstraZeneca | Cafepharma
AstraZeneca broke ground today on a massive manufacturing complex near Charlottesville, Virginia, its largest facility worldwide and a cornerstone of the company’s $50 billion U S R D and manufacturing plan through 2030 The company intends to ramp up investment and scope of the facility to $4 5 billion, which would eventually create 3,600 new jobs as the site expands
- July 24 2025 - AstraZeneca drug acquired in Alexion deal succeeds in . . .
AstraZeneca drug acquired in Alexion deal succeeds in autoimmune disease trialAstraZeneca boardPharma giant Roche sees income soar in first halfRoche boardNovartis to pay Matchpoint up to $1 billion to develop anti-inflammatory therapiesNovartis boardHow Bristol Myers Squibb uses AI to validate drugs before they’re even in the lab
|
|
|